United States Antimony (UAMY) is back in focus after updating investors on third quarter deliveries of Military Specification antimony ingots under its sole source US$245 million Defense Logistics Agency contract.
Against this contract backdrop, United States Antimony's share price has retreated, with a 7 day share price return down 9.6% and a 90 day share price return down 44.4% at a recent price of US$4.13, even though the 3 year total shareholder return is very large.
Scan beyond United States Antimony and compare this defense-linked producer with 33 best rare earth metal stocks that could also be levered to critical materials demand and government supply chain priorities.
Bulls point to United States Antimony's sole source defense contract and rapid top line expansion. Bears see the sharp share price pullback and ongoing losses. Which side does the current valuation actually support next?
Most Popular Narrative: 63% Undervalued
On the most followed view, United States Antimony screens cheaply, with a narrative fair value of $11.19 against a last close of $4.13. That gap only looks meaningful if the growth, margin and contract assumptions behind it hold up.
US Antimony is expanding its domestic processing capacity (for example, a sixfold increase at the Thompson Falls facility expected by year-end) and increasing ore supply both from its own Montana/Alaska projects and multiple new international sources, which should drive higher production volumes and sustained revenue growth through increased throughput and supply security.
The company is in late-stage discussions with U.S. government agencies (including DoD and DLA) regarding critical mineral offtake and funding. Any resulting contracts or incentives would provide long-term, recurring, premium-priced revenue and earnings, leveraging the strategic value of being the only domestic antimony processor as U.S. policy shifts toward supply chain security and China de-risking.
See why 81 investors see United States Antimony as 63% undervalued .
Result: Fair Value of $11.19 (UNDERVALUED)
Still, permitting setbacks at Alaska and Ontario projects and ongoing ore quality issues could quickly challenge the bullish United States Antimony capacity and margin story.
Find out about the key risks to this United States Antimony narrative .
Another View: United States Antimony On Sales-Based Valuation
On a simple sales yardstick, United States Antimony looks expensive. The stock trades at a P/S ratio of 17x, compared with 5.7x for peers and 3.1x for the wider US Metals and Mining group, while the fair ratio is estimated at 4.3x. That gap points to meaningful valuation risk if revenue or margins fall short of expectations.
Investors weighing these signals may want to ask whether the premium P/S hints at a story that the SWS DCF model does not fully capture, or whether it simply leaves less room for error if the growth narrative around United States Antimony cools.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals around United States Antimony can be confusing, so move fast, look through the data yourself, and weigh both sides using the 2 key rewards and 3 important warning signs
Looking For More Investment Ideas Beyond United States Antimony?
If United States Antimony has you thinking harder about risk, reward, and timing, widen your watchlist using a few targeted stock ideas built from the Simply Wall Street Screener.
-
Target potential mispricing by scanning companies that combine quality fundamentals with attractive valuations through the 28 high quality undervalued stocks .
-
Stack your income stream by checking out stocks screened for reliable high yields using the 7 dividend fortresses .
-
Lean toward resilience by focusing on businesses highlighted for stronger finances and balance sheet strength via the list of solid balance sheet and fundamentals (25 results) .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include UAMY .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
